Quantum Cyber N.V. Ordinary Shares (QUCY)
Stock · NASDAQ · Health Care
$1.07as of 10/16/2026
Price chart
Active signals
QUCY Signal Track Record
How signals performed across all stocks →What QUCY's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 47 | -17.8% | 11% | October 7, 2026 |
| Bollinger Band Breakdown | 19 | -9.2% | 42% | May 5, 2026 |
| Bollinger Band Breakout | 16 | -19.2% | 13% | October 7, 2026 |
| Any 20-session window (baseline) | -10.6% | 28% |
Computed by MarketWall from daily closing prices since August 23, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About QUCY
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 10
- Website
- quantum-cyber.ai
Fundamentals
- 1-day range
- $1.05$1.12
- Market cap
- $31.42M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-1.94
- Dividend yield
- —
- Beta
- 2.46
- Avg. volume
- 678.6K
Forecasts
1 analyst ratings
Quantum Cyber N.V. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- QUCYQuantum Cyber N.V. Ordinary Shares$1.06▼ 2.75%Market cap $31.42MP/E —$0.3$4.93
- UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares$3.93▼ 5.30%Market cap $31.35MP/E —$2$17.96
- LITSLite Strategy Inc. Common Stock$1.15▼ 4.17%Market cap $31.61MP/E —$0.6888$2.26
- BCTXBriaCell Therapeutics Corp. Common Shares$3.4▼ 9.81%Market cap $30.01MP/E —$3.68$20.4
- ENLVEnlivex Ltd. Ordinary Shares$0.205▼ 8.48%Market cap $33.33MP/E 0.00$0.21$27.15
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| QUCY Quantum Cyber N.V. Ordinary Shares | $31.42M | — | $1.06 | ▼ 2.75% | $0.3$4.93 |
| UPC Universe Pharmaceuticals Inc. Class A Ordinary Shares | $31.35M | — | $3.93 | ▼ 5.30% | $2$17.96 |
| LITS Lite Strategy Inc. Common Stock | $31.61M | — | $1.15 | ▼ 4.17% | $0.6888$2.26 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.4 | ▼ 9.81% | $3.68$20.4 |
| ENLV Enlivex Ltd. Ordinary Shares | $33.33M | 0.00 | $0.205 | ▼ 8.48% | $0.21$27.15 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Quantum Cyber Files Audited and Reviewed Financial Statements and Pro Forma Financial Information for Bridgeport Manufacturing AcquisitionYahoo · 9/28/2026
- Quantum Cyber Sharpens Strategic Focus to Quantum Navigation, Interceptor Drones, and U.S. Manufacturing, and Presents New Corporate Investor PresentationYahoo · 9/25/2026
Insider Activity
Insider Actions →- William J. Caragol · August 11, 2026 · Grant212.5K
- David E. Lazar · August 5, 2026 · Conversion124.7K
- David E. Lazar · August 5, 2026 · Conversion1.00M
- David E. Lazar · August 5, 2026 · Conversion28.06M @ $225
- David E. Lazar · August 5, 2026 · Conversion9.00M @ $9
- Avraham Ben-Tzvi · July 31, 2026 · Grant112.3K
- O'Rourke Peter · July 31, 2026 · Grant190.8K
- Buffalino Louis R. · July 31, 2026 · Grant425.0K
- William J. Caragol · July 31, 2026 · Grant212.5K
- David Natan · July 31, 2026 · Grant190.8K
- O'Rourke Peter · July 22, 2026 · Grant191.9K
- Avraham Ben-Tzvi · July 22, 2026 · Grant112.9K
- Buffalino Louis R. · July 22, 2026 · Grant425.0K
- William J. Caragol · July 22, 2026 · Grant212.5K
- David Natan · July 22, 2026 · Grant191.9K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Quantum Cyber Reports Audited Financials and Refines Strategic Focus
Quantum Cyber has released audited and reviewed financial statements for its Bridgeport Manufacturing acquisition. In a new investor presentation, the firm highlighted a sharpened focus on quantum navigation, interceptor drones, and U.S. manufacturing. These updates outline the company’s progress on the acquisition and its strategic priorities moving forward.
Quantum Cyber Reports Audited Financials and Refines Strategic Focus. Quantum Cyber has released audited and reviewed financial statements for its Bridgeport Manufacturing acquisition. In a new investor presentation, the firm highlighted a sharpened focus on quantum navigation, interceptor drones, and U.S. manufacturing. These updates outline the company’s progress on the acquisition and its strategic priorities moving forward.